Viramal
UK - LondonBiotechnology
Focus: Viramal is a UK-based biotechnology company founded in 2013, focused on women's health therapeutics with a pipeline in early-stage development. The company operates as a pre-revenue biotech with three active clinical programs across menopause, endometriosis, and vaginal atrophy.
Profile data last refreshed 19h ago · AI intelligence enriched 6d ago
Open Jobs
0
About Viramal
AI assessmentNot HiringNo open roles listed right now. Follow Viramal to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Viramal's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
VML-0001
Vaginal AtrophyClinical Trials (1)
NCT03770065Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women
N/AHelp build intelligence for Viramal
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.